AMRX PDUFA decision: a negative outcome, -5.4%

On September 21, 2020, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a negative outcome, and the stock moved -5.4% in the window around the event. It had already run +8.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.